W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

News

Summary of information indicated by applicants to be kept confidential in selected areas of the documentation published by AOTMiT (applicant’s analyses, verification analyses, positions of the Transparency Council, recommendations of the President) in the evaluation of reimbursement applications for the year 2021 and Q1 2022.

more...

Opinion of the Transparency Council – dexamethasone

more...

Opinion of the Transparency Council – amendments to part B of the drug programme B.70

more...

Opinion of the Transparency Council – health policy programme of the City of Białystok

more...

Opinion of the Transparency Council – health policy programme of the City of Zduńska Wola

more...

Position of the Transparency Council – Adtralza (tralokinumab)

more...

Meeting of the Transparency Council 20/2023 on 22 May 2023 – Update

more...

Communication on the meeting of the Tariff Council on 20 April 2023

more...

Communication on the meeting of the Tariff Council on 11 May 2023

more...

The Transparency Council meeting 20/2023 on 22 May 2023

more...

Opinion of the Transparency Council – desmopressin

more...

Opinion of the Transparency Council – fentanyl

more...

Opinion of the Transparency Council – paclitaxel

more...

Opinion of the Transparency Council – carboplatin

more...

Position of the Transparency Council – Forxiga (dapagliflozin)

more...

Position of the Transparency Council – Forxiga (dapagliflozin)

more...

Opinion of the Transparency Council – e-stethoscopes

more...

Opinion of the Transparency Council – health policy programme of the Municipality of Kamieniec Ząbkowicki

more...

Opinion of the Transparency Council – health policy programme of the Municipality of Piaseczno

more...

The Transparency Council meeting 19/2023 on 15 May 2023

more...

Opinion of the Transparency Council – lisinopril + amlodipine

more...

Opinion of the Transparency Council – candesartan + amlodipine

more...

Opinion of the Transparency Council – candesartan + hydrochlorothiazide

more...

Opinion of the Transparency Council – amlodipine + valsartan+ hydrochlorothiazide

more...